Beijing Beier Bioengineering Co.,Ltd.

Beijing Beier Bioengineering Co., Ltd. (referred to as Beier ) was established in 1995 as a high-tech enterprise specializing in the R&D, production, and sales of in vitro diagnostic (IVD) reagents and supporting instruments. It is also recognized as a national-level Specialized, Refined, Distinctive, and Innovative Little Giant enterprise. Over its 30-year history, Beier has consistently prioritized independent R&D and regarded technological innovation as its primary driving force. The company has established eight major technology platforms, including ELISA diagnostic reagents, POCT rapid test reagents, magnetic particle chemiluminescence diagnostic reagents, molecular diagnostic reagents, biochemical diagnostic reagents, mass spectrometry diagnostic reagents, medical instruments, and biomaterials. With a complete industrial chain covering reagents, instruments, and quality control products, Beier is one of China's leading IVD companies with a diverse product portfolio, capable of providing clinical laboratories with comprehensive, one-stop testing solutions. For three decades, Beier has focused on clinical testing needs and was among the first in China to develop product lines for prenatal and postnatal care, respiratory diseases, EB virus, hepatitis viruses, autoantibodies, and tumor markers, offering a wide range of diagnostic solutions. To date, the company has obtained 458 domestic medical registration certificates, making it one of the most comprehensive providers of immunodiagnostic products in the IVD field.